Related Experiment Video
Updated: Aug 11, 2026
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Self-Stimulated Photodynamic Nanoreactor in Combination with CXCR4 Antagonists for Antileukemia Therapy
Yan Zhang1, Liang Chen1, Ting Fu1
1School of Laboratory Medicine, Hangzhou Medical College, 310053 Hangzhou, Zhejiang, China.
Abstract:
The treatment of acute myeloid leukemia (AML) remains unsatisfactory, owing to the absence of efficacious therapy regimens over decades. However, advances in molecular biology, including inhibiting the CXCR4/CXCL12 biological axis, have introduced novel therapeutic options for AML. Additionally, self-stimulated phototherapy can solve the poor light penetration from external sources, and it will overcome the limitation that traditional phototherapy cannot be applied to the treatment of AML. Herein, we designed and manufactured a self-stimulated photodynamic nanoreactor to enhance antileukemia efficacy and suppress leukemia recurrence and metastasis in AML mouse models. To fulfill our design, we utilized the CXCR4/CXCL12 biological axis and biomimetic cell membranes in conjunction with self-stimulated phototherapy. This nanoreactor possesses the capability to migrate into the bone marrow cavity, inhibit AML cells from infiltrating into the visceral organ, significantly enhance the antileukemia effect, and prolong the survival time of leukemic mice. Therefore, this nanoreactor has significant potential for achieving high success rates and low recurrence rates in leukemia treatment.
Insights
Novel nanoreactors target acute myeloid leukemia (AML) by inhibiting the CXCR4/CXCL12 axis and using self-stimulated phototherapy. This approach enhances anti-leukemia effects and reduces recurrence in mouse models.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Acute myeloid leukemia (AML) treatment remains challenging due to limited effective therapies.
- Advances in molecular biology offer new therapeutic targets, such as the CXCR4/CXCL12 axis.
- Traditional phototherapy faces limitations in treating AML due to poor light penetration.
Purpose of the Study:
- To design and fabricate a self-stimulated photodynamic nanoreactor for enhanced AML treatment.
- To leverage the CXCR4/CXCL12 axis and biomimetic cell membranes for targeted therapy.
- To improve therapeutic efficacy and suppress leukemia recurrence and metastasis.
Main Methods:
- Development of a nanoreactor incorporating biomimetic cell membranes and self-stimulated phototherapy.
- Utilizing the CXCR4/CXCL12 axis for targeted delivery and action within AML models.
- Evaluation of the nanoreactor's efficacy in AML mouse models, including bone marrow migration and organ infiltration inhibition.
Main Results:
- The nanoreactor successfully migrated into the bone marrow cavity.
- It effectively inhibited AML cell infiltration into visceral organs.
- Significant enhancement of anti-leukemia effects and prolonged survival time were observed in leukemic mice.
Conclusions:
- The developed nanoreactor shows potential for treating AML by enhancing therapeutic efficacy.
- This approach may lead to high success rates and reduced recurrence in leukemia treatment.
- The combination of targeting the CXCR4/CXCL12 axis and self-stimulated phototherapy offers a promising strategy for AML therapy.
